✦ LIBER ✦

649 A Randomized Placebo-Controlled Trial of Abatacept for Moderately-to-Severely Active Crohn's Disease (CD)

✍ Scribed by Stephen B. Hanauer; William J. Sandborn; Bruce E. Sands; Paul J. Rutgeerts; Remo Panaccione; Brian Bressler; Marvilyn A. Whiteside; René Swanink; Richard Aranda; Allison Luo

Book ID: 119431244
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 76 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(10)60394-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Onercept for Moderate-to-Severe Crohn’s

Onercept for Moderate-to-Severe Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Rutgeerts, Paul; Sandborn, William J.; Fedorak, Richard N.; Rachmilewitz, Daniel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A randomized controlled trial of CDP571,

A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease

✍ Sanborn, William J.; Targan, Stephan R.; Hanauer, Stephan B.; Present, Daniel H. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Etanercept for Active Crohn's Disease: A

Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ William J. Sandborn; Stephen B. Hanauer; Seymour Katz; Michael Safdi; Douglas G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 181 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

✍ J. C. MANSFIELD; M. PARKES; A. B. HAWTHORNE; A. FORBES; C. S. J. PROBERT; R.C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

A Randomized, Placebo-Controlled Trial o

A Randomized, Placebo-Controlled Trial of MDX-1100, an Anti-IP-10 Antibody, for Moderately to Severely Active Ulcerative Colitis

✍ Lloyd Mayer; William J. Sandborn; Yuriy Stepanov; Judith Maccarone; Xiaolu Tao; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 118 KB